Kieran Ryan Analyst Performance

Analyst at Deutsche Bank Aktiengesellschaft

Kieran Ryan is a stock analyst at Deutsche Bank Aktiengesellschaft in the medical sector, covering 3 publicly traded companies. Over the past year, Kieran Ryan has issued 3 stock ratings, including buy and hold recommendations. While full access to Kieran Ryan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kieran Ryan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
66.67% 2 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%2 ratings
Hold33.3%1 ratings
Sell0.0%0 ratings

Out of 3 total stock ratings issued by Kieran Ryan at Deutsche Bank Aktiengesellschaft, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Kieran Ryan, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
100.0%

Kieran Ryan of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
2 companies
66.7%
MED PRODUCTS
1 company
33.3%

Kieran Ryan's Ratings History at Deutsche Bank Aktiengesellschaft

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
DexCom, Inc. stock logo
DXCM
DexCom
6/23/2026Initiated Coverage$69.07$86.00Buy
Insulet Corporation stock logo
PODD
Insulet
6/23/2026Initiated Coverage$138.97$190.00Buy
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
6/23/2026Initiated Coverage$14.34$15.50Hold